Mark Scapens
Direktor/Vorstandsmitglied bei CANNASOUTH LIMITED
Aktive Positionen von Mark Scapens
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| CANNASOUTH LIMITED | Direktor/Vorstandsmitglied | - | - |
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Mark Scapens
Ehemalige bekannte Positionen von Mark Scapens
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Aspire2 Group Ltd.
 Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Neuseeland | 4 |
Operativ
| Director/Board Member | 3 |
Sektoral
| Health Technology | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Aspire2 Group Ltd.
Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Commercial Services |
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Börse
- Insiders
- Mark Scapens
- Erfahrung